Nordic American Tankers Limited Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Nordic American Tankers Limited Common Stock trades at $8.2 (market cap $1.86B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: NeoGenomics Inc. Common Stock is the larger of the two by market cap, and Nordic American Tankers Limited Common Stock pays a 12.29% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nordic American Tankers Limited Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| NAT | NEO | |
|---|---|---|
Market Cap | $1.86B | $2.14B |
Volume | 5,330,493 | 2,228,400 |
Sector | Industrials | Health |
52-Week High | $8.79 | $19.91 |
52-Week Low | $3.26 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.13B | $2.44B |
Dividend Yield | 12.29% | — |
Signals from Pluang's Aura AI — not financial advice
NAT trades at $8.79, matching its 52-week high, reflecting strong momentum amid favorable tanker market conditions. The stock shows robust fundamentals with a 33.34% net income margin and 25.66% ROE for 2026, while Q2 2026 EPS beat expectations. Technical indicators are neutral, with support and resistance clustered around $9. Recent news highlights surging spot rates and insider buying by the Hansson family, underscoring confidence in near-term prospects.
Outlook is positive due to elevated freight rates and earnings growth, but risks include volatility in tanker rates and geopolitical tensions. Analysts are mixed with a $3.50 consensus target, suggesting caution despite operational strength. The stock's high yield and momentum offer appeal, though sustainability of current rates remains a key monitorable.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nordic American Tankers Limited is a Bermuda-based shipping company specializing exclusively in Suezmax crude-oil tankers, which it charters in the spot and period markets on international routes. The company has paid a dividend every quarter since 1997.
Read more on NAT →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →